Código QR (código de barras bidimensional)

A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck

Abstract Background Induction chemotherapy (IC) in locally advanced squamous cell carcinoma of the head and neck (LA‐SCCHN) often compromises compliance with subsequent chemoradiotherapy (CRT), which negatively affects outcomes. Here, we assessed the combination of paclitaxel (PTX), carboplatin (CBD...

Fuld beskrivelse

Na minha lista:
Principais autores: Tomohiro Enokida, Takenori Ogawa, Akihiro Homma, Kenji Okami, Shujiro Minami, Ayako Nakanome, Yasushi Shimizu, Daisuke Maki, Yuri Ueda, Takao Fujisawa, Atsushi Motegi, Akira Ohkoshi, Jun Taguchi, Koji Ebisumoto, Shogo Nomura, Susumu Okano, Makoto Tahara
Format: Artigo
Sprog:Inglês
Udgivet: Wiley 2020-03-01
Serier:Cancer Medicine
Fag:
carboplatin
cetuximab
chemoradiotherapy
induction chemotherapy
paclitaxel
unresectable locally advanced squamous cell carcinoma of the head and neck
Online adgang:https://doi.org/10.1002/cam4.2852
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker